Clinical Research
corporate_fare

Nchroma Bio Inc.

Address
201 Brookline Avenue Suite 1101

Sponsor Overview

assignment
1
sponsored trial
science
1
molecule
location_city
1
research centre
public
1
country
person_search
1
investigator

Specializations

Chronic Hepatitis B

Chronic Hepatitis B is the central therapeutic area in the sponsor’s clinical research activity, with interest focused on antiviral treatment and disease control in a persistent liver infection.

  • Hepatitis B virus
  • Liver disease
  • Antiviral therapy

The sponsor’s research activity in this area aligns with the development of therapies aimed at managing viral persistence and improving outcomes in chronic viral hepatitis.

Virology and Antiviral Development

The clinical program reflects a strong interest in virology, particularly therapies designed to address the underlying biology of hepatitis B infection and related immune responses.

  • Viral replication
  • Host-virus interaction
  • Antiviral drug development

This therapeutic focus supports research into agents intended to modify the course of HBV infection and reduce disease burden.

Pharmacokinetics and Pharmacodynamics

Research activity also includes evaluation of pharmacokinetics and pharmacodynamics, indicating interest in how investigational therapies behave in the body and influence biological targets relevant to hepatitis B.

  • Drug exposure
  • Target engagement
  • Biological activity

These areas are important for understanding therapeutic performance in liver-related infectious disease.

Safety and Tolerability

The sponsor is actively engaged in assessing safety and tolerability, with clinical interest in how investigational treatment candidates are received in people living with chronic hepatitis B.

  • Adverse events
  • Clinical tolerability
  • Patient safety

This area remains closely tied to the development of new options for infectious liver disease.

Efficacy in Chronic Viral Infection

Clinical interest extends to efficacy in chronic viral infection, with attention to treatment effects that may influence disease activity and longer-term control of HBV.

  • Therapeutic response
  • Viral suppression
  • Disease management

The sponsor’s research in this domain is centered on advancing options for patients affected by persistent hepatitis B infection.

Sponsored Trials

Trial Name Country Status
A Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of CRMA-1001 in Adults with Chronic Hepatitis BFrance FranceNot Yet Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 1 total (100% not shared with other sponsors)

This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 1 sites collaborated multiple times

This sponsor has worked with 1 site across their trial portfolio.

Therapeutic Focus

  • 1.
    Virus Diseases1 trial
    182 other sponsors

Partnered Research Centres

1 centre
location_city
assignment27
Hospices Civils De Lyon
Address
103 Grande Rue De La Croix Rousse, 69317 Lyon
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Nchroma Bio Inc..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.